Although synchronous axillary lymph node metastasis is not considered as distant metastasis, one hypothesis could be that these patients might benefit from treatment with HER2-directed antibody drug conjugates. Here, ERBB2 is linked to metastatic malignant neoplasm in the lymph nodes.